Cite
APA Citation
Alroughani, R. (2014). high discontinuation rate of natalizumab in JC virus seropositive patients due to significant anxiety and safety feelings. Multiple sclerosis, 20, 1667–1668. http://access.bl.uk/ark:/81055/vdc_100058195202.0x00001e